| Literature DB >> 35305695 |
Yun-Xing Xue1,2, Jun-Xia Wang1,2, Xi-Yu Zhu1,2, Ho-Shun Chong1,2, Zhong Chen1,2, Qing Zhou1,2, Jason-Zhensheng Qu3, Dong-Jin Wang4,5.
Abstract
BACKGROUND: Acute type A aortic dissection (aTAAD) is a lethal disease and age is an important risk factor for outcomes. This retrospective study was to analyze the impact of age stratification in aTAAD, and to provide clues for surgeons when they make choices of therapy strategies.Entities:
Keywords: Age; Aortic dissection; Surgical therapy
Mesh:
Year: 2022 PMID: 35305695 PMCID: PMC8933992 DOI: 10.1186/s13019-022-01785-y
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1a Number and sex ratio of patients in different age groups of our center; b The reason for non-surgery after admission. The main reason was a rupture
Baseline demographics and characteristics
| Total | 20 s | 30 s | 40 s | 50 s | 60 s | 70 s | 80 s | P value | |
|---|---|---|---|---|---|---|---|---|---|
| Number | 1092 | 32 | 146 | 281 | 286 | 211 | 118 | 18 | |
| Age | 52 (62–44) | 27 (28–25) | 35.5(38–32) | 45 (47–43) | 54 (56–52) | 64 (66–62) | 74 (76–71) | 82.5(84.25–80) | < 0.001 |
| Male | 816 (74.7%) | 30 (93.8%) | 127 (87.0%) | 244 (86.8%) | 211 (73.8%) | 130 (61.6%) | 64 (54.2%) | 10 (55.6%) | < 0.001 |
| BMI (kg/m2) | 25.6 ± 4.6 | 25.8 ± 5.4 | 27.4 ± 5.7 | 26.4 ± 4.7 | 25.4 ± 4.1 | 24.7 ± 4.0 | 24.1 ± 3.9 | 23.4 ± 3.9 | < 0.001 |
| Hypertension | 807 (73.9%) | 12 (37.5%) | 95 (65.1%) | 215 (76.5%) | 219 (76.6%) | 162 (76.8%) | 92 (78.0%) | 12 (66.7%) | < 0.001 |
| Marfan | 26 (2.4%) | 9 (28.1%) | 4 (2.7%) | 10 (3.6%) | 2 (0.7%) | 1 (0.5%) | 0 (0%) | 0 (0%) | < 0.001 |
| Diabetes | 40 (3.7%) | 0 (0%) | 3 (2.1%) | 8 (2.8%) | 9 (3.1%) | 11 (5.2%) | 7 (5.9%) | 2 (11.1%) | 0.181 |
| Smoke | 250 (22.9%) | 10 (31.3%) | 34 (23.3%) | 77 (27.4%) | 71 (24.8%) | 40 (19.0%) | 14 (11.9%) | 4 (22.2%) | 0.019 |
| Alcohol | 167 (15.3%) | 3 (9.4%) | 28 (19.2%) | 44 (15.7%) | 54 (18.9%) | 25 (11.8%) | 11 (9.3%) | 2 (11.1%) | 0.098 |
| End stage kidney disease | 23 (2.1%) | 0 (0.0%) | 4 (2.7%) | 5 (1.8%) | 11(3.8%) | 0 (0.0%) | 3 (2.5%) | 0 (0.0%) | 0.072 |
| Stroke history | 31 (2.8%) | 0 (0%) | 1 (0.7%) | 5 (1.8%) | 7 (2.4%) | 5 (2.4%) | 10 (8.5%) | 3 (16.7%) | 0.001 |
| CAD history | 27 (2.5%) | 0 (0%) | 2 (1.4%) | 3 (1.1%) | 5 (1.7%) | 9 (4.3%) | 6 (5.1%) | 2 (11.1%) | 0.020 |
| COPD history | 11 (1.0%) | 0 (0%) | 1 (0.7%) | 2 (0.7%) | 3 (0.3%) | 3 (1.4%) | 2 (3.4%) | 0 (0%) | 0.919 |
| AF history | 10 (0.9%) | 0 (0%) | 1 (0.7%) | 1 (0.4%) | 2 (0.7%) | 3 (1.4%) | 2 (1.7%) | 1 (5.6%) | 0.273 |
| Pain | 1007 (92.3%) | 28 (87.5%) | 134 (91.8%) | 262 (93.2%) | 264 (92.3%) | 194 (91.9%) | 109 (92.4%) | 17 (94.4%) | 0.936 |
| Chest | 942 (86.3%) | 28 (87.5%) | 125 (85.6%) | 244 (86.8%) | 251 (87.8%) | 179 (84.8%) | 102 (86.4%) | 15 (83.3%) | 0.965 |
| Back | 433 (39.7%) | 9 (28.1%) | 59 (40.4%) | 110 (39.1%) | 122 (42.7%) | 78 (37.0%) | 50 (42.4%) | 5 (27.8%) | 0.565 |
| Abdominal | 59 (5.4%) | 0 (0%) | 10 (6.8%) | 19 (6.8%) | 12 (4.2%) | 10 (4.7%) | 5 (4.2%) | 3 (16.7%) | 0.197 |
| Leg | 32 (2.9%) | 2 (6.3%) | 5 (3.4%) | 9 (3.2%) | 8 (2.8%) | 6 (2.8%) | 2 (1.7%) | 0 (0%) | 0.848 |
| Malperfusion | |||||||||
| Cerebral | 108 (9.9%) | 0 (0%) | 9 (6.2%) | 26 (9.3%) | 32 (11.2%) | 21 (10%) | 19 (16.1%) | 1 (5.6%) | 0.062 |
| Limb | 165 (15.1%) | 7 (21.9%) | 20 (13.7%) | 49 (17.4%) | 46 (16.1%) | 30 (14.2%) | 12 (10.2%) | 1 (5.6%) | 0.397 |
| Bowel | 47 (4.3%) | 0 (0%) | 4 (2.7%) | 13 (4.6%) | 13 (4.5%) | 10 (4.7%) | 7 (5.9%) | 0 (0%) | 0.666 |
| Myocardial | 52 (4.8%) | 2 (6.3%) | 11 (7.5%) | 10 (3.6%) | 14 (4.9%) | 10 (4.7%) | 5 (4.2%) | 0 (0%) | 0.646 |
| Hypotension | 64 (5.9%) | 1 (3.1%) | 4 (2.7%) | 11 (3.9%) | 20 (7.0%) | 19 (9.0%) | 6 (5.1%) | 3 (16.7%) | 0.040 |
| Pericardial tamponade | 131 (12.0%) | 4 (12.5%) | 5 (3.4%) | 26 (9.3%) | 39 (13.6%) | 34 (16.1%) | 22 (18.6%) | 1 (5.6%) | 0.001 |
| Coronary artery involvement | 215 (19.7%) | 11 (34.4%) | 28 (19.2%) | 53 (18.9%) | 62 (21.7%) | 39 (18.5%) | 21 (17.8%) | 1 (5.6%) | 0.278 |
BMI body mass index, CAD coronary artery disease, COPD chronic obstructive pulmonary disease
Operative data
| Total | 20 s | 30 s | 40 s | 50 s | 60 s | 70 s | 80 s | P value | |
|---|---|---|---|---|---|---|---|---|---|
| Number | 1092 | 32 | 146 | 281 | 286 | 211 | 118 | 18 | |
| Hour from onset to admission | 10 (18–6) | 10 (20–6) | 10 (18–7) | 10 (18–7) | 9 (16–6) | 10 (20–6) | 10 (18–6) | 9 (12–5) | 0.374 |
| Hours from admission to surgery | 6 (12–3) | 9 (12–3) | 6 (13–3) | 6 (14–3) | 5 (12–3) | 5 (12–2) | 5 (10–3) | 6 (12–3) | 0.049 |
| OP duration | 8.0 ± 2.1 | 8.2 ± 2.1 | 8.2 ± 2.1 | 8.3 ± 2.2 | 7.8 ± 2.3 | 7.7 ± 1.9 | 7.7 ± 1.9 | 7.1 ± 1.6 | < 0.001 |
| Cannulation | |||||||||
| Ascending | 20 (1.8%) | 2 (6.3%) | 3 (2.1%) | 5 (1.8%) | 3 (1.0%) | 5 (2.4%) | 2 (1.7%) | 0 (0%) | 0.521 |
| Femoral | 231 (21.2%) | 7 (21.9%) | 18 (12.3%) | 36 (12.8%) | 68 (23.8%) | 61 (28.9%) | 33 (28.0%) | 8 (44.4%) | 0.000 |
| Axillary | 233 (21.3%) | 3 (9.4%) | 25 (17.1%) | 64 (22.8%) | 56 (19.6%) | 50 (23.7%) | 30 (25.4%) | 5 (27.8%) | 0.281 |
| Femoral + axillary | 608 (55.7%) | 20 (62.5%) | 100 (68.5%) | 176 (62.6%) | 159 (55.6%) | 95 (45.0%) | 53 (44.9%) | 5 (27.8%) | 0.000 |
| HCA | 30.3 ± 11.1 | 29.2 ± 15.6 | 32.4 ± 12.6 | 30.7 ± 10.8 | 29.7 ± 10.8 | 30.6 ± 11.1 | 28.7 ± 8.5 | 24.8 ± 8.7 | 0.021 |
| CPB | 240.0 ± 76.1 | 238.8 ± 64.4 | 253.6 ± 74.2 | 245.9 ± 81.4 | 237.7 ± 76.7 | 234.7 ± 75.9 | 228.3 ± 66.9 | 219.3 ± 61.1 | 0.012 |
| X-clamp | 166.8 ± 61.1 | 168.5 ± 47.4 | 179.8 ± 59.3 | 169.8 ± 72.3 | 164.1 ± 57.6 | 163.1 ± 57.8 | 157.8 ± 49.1 | 159.7 ± 59.8 | 0.049 |
| Cerebral perfusion | < 0.001 | ||||||||
| No perfusion | 140 (12.8%) | 7 (21.9%) | 10 (6.8%) | 23 (8.2%) | 43 (15.0%) | 39 (18.5%) | 14 (11.9%) | 4 (22.2%) | |
| ACP | 886 (81.1%) | 25 (78.1%) | 130 (89.0%) | 250 (89.0%) | 226 (79.0%) | 153 (72.5%) | 91 (77.1%) | 11 (61.1%) | |
| RCP | 66 (6.0%) | 0 (0%) | 6 (4.1%) | 8 (2.8%) | 17 (5.9%) | 19 (9.0%) | 13 (11.0%) | 3 (16.7%) | |
| Root procedure | < 0.001 | ||||||||
| No | 17 (1.6%) | 2 (6.3%) | 2 (1.4%) | 5 (1.8%) | 3 (1.0%) | 3 (1.4%) | 2 (1.7%) | 0 (0%) | |
| Root reconstruction | 828 (75.8%) | 13 (40.6%) | 99 (67.8%) | 213 (75.8%) | 214 (74.8%) | 174 (82.5%) | 101 (85.6%) | 14 (77.8%) | |
| Bentall | 228 (20.9%) | 14 (43.8%) | 38 (26.0%) | 60 (21.4%) | 68 (23.8%) | 30 (14.2%) | 14 (11.9%) | 4(22.2%) | |
| VSRR | 19 (1.7%) | 3 (9.4%) | 7 (4.8%) | 3 (1.1%) | 1 (0.3%) | 4 (1.9%) | 1 (0.8%) | 0 (0%) | |
| Arch procedure | < 0.001 | ||||||||
| Sub-arch | 211 (19.9%) | 7 (21.9%) | 18 (12.3%) | 40 (14.2%) | 49 (17.1%) | 47 (22.3%) | 45 (38.1%) | 7 (38.9%) | |
| Total arch + FET | 515 (47.1%) | 19 (59.4%) | 88 (60.3%) | 156 (55.5%) | 131 (45.8%) | 88 (41.7%) | 31 (26.3%) | 3 (16.7%) | |
| Arch stent | 361 (33.0%) | 6 (18.8%) | 40 (27.4%) | 85 (30.2%) | 106 (37.1%) | 74 (35.1%) | 41 (34.7%) | 8 (44.4%) | |
OP operation, HCA hypothermic circulatory arrest, CPB cardiopulmonary bypass, ACP antegrade cerebral perfusion, RCP retrograde cerebral perfusion, VSRR valve sparing root reconstruction, FET frozen elephant trunk technique
Postoperative data
| Total | 20 s | 30 s | 40 s | 50 s | 60 s | 70 s | 80 s | P value | |
|---|---|---|---|---|---|---|---|---|---|
| Number | 1092 | 32 | 146 | 281 | 286 | 211 | 118 | 18 | |
| 30 day-mortality | 154 (14.1%) | 5 (15.6%) | 11 (7.5%) | 33 (11.7%) | 41 (14.3%) | 36 (17.1%) | 22 (18.6%) | 6 (33.3%) | 0.016 |
| Mechanical ventilation | 56.2 ± 79.1 | 71.6 ± 130.2 | 61.2 ± 90.4 | 55.2 ± 69.6 | 57.5 ± 93.8 | 52.9 ± 63.3 | 49.3 ± 51.0 | 67.6 ± 80.4 | 0.808 |
| Reintubation | 70 (6.4%) | 4 (12.5%) | 6 (4.1%) | 14 (5.0%) | 23 (8.0%) | 12 (5.7%) | 11 (9.3%) | 0 (0%) | 0.199 |
| Tracheotomy | 44 (4.0%) | 2 (6.3%) | 4 (2.7%) | 11 (3.9%) | 10 (3.5%) | 7 (3.3%) | 10 (8.5%) | 0 (0%) | 0.216 |
| ICH | 9 (0.8%) | 0 (0%) | 1 (0.7%) | 1 (0.4%) | 5 (1.7%) | 1 (0.5%) | 1 (0.8%) | 0 (0%) | 0.609 |
| Stroke | 59 (5.4%) | 0 (0%) | 3 (2.1%) | 14 (5.0%) | 17 (5.9%) | 18 (8.5%) | 6 (5.1%) | 1 (5.6%) | 0.155 |
| Paraplegia | 23 (2.1%) | 0 (0%) | 4 (2.7%) | 9 (3.2%) | 7 (2.4%) | 2 (0.9%) | 1 (0.8%) | 0 (0%) | 0.489 |
| GI bleeding | 13 (1.2%) | 0 (0%) | 1 (0.7%) | 4 (1.4%) | 4 (1.4%) | 0 (0%) | 1 (0.8%) | 3 (16.7%) | 0.000 |
| Limb ischemia | 13 (1.2%) | 0 (0%) | 1 (0.7%) | 5 (1.8%) | 2 (0.7%) | 5 (2.4%) | 0 (0%) | 0 (0%) | 0.396 |
| Bowel ischemia | 16 (1.5%) | 0 (0%) | 3 (2.1%) | 3 (1.1%) | 3 (1.0%) | 2 (0.9%) | 3 (2.5%) | 2 (11.1%) | 0.025 |
| Surgical site infection | 37 (3.4%) | 2 (6.3%) | 3 (2.1%) | 10 (3.6%) | 9 (3.1%) | 11 (5.2%) | 2 (1.7%) | 0 (0%) | 0.484 |
| Acute renal failure | 339 (31.0%) | 10 (31.3%) | 50 (34.2%) | 89 (31.7%) | 97 (33.9%) | 56 (26.5%) | 31 (26.3%) | 6 (33.3%) | 0.525 |
| CRRT | 127 (11.6%) | 2 (6.3%) | 14 (9.6%) | 35 (12.5%) | 28 (9.8%) | 27 (12.8%) | 16 (13.6%) | 5 (27.8%) | 0.246 |
| Reexploration | 64 (5.8%) | 0 (0%) | 6 (4.1%) | 14 (5.0%) | 26 (9.1%) | 11 (5.2%) | 6 (5.1%) | 0 (0%) | 0.119 |
| ICU stay (days) | 5 (8–3) | 4 (6–3) | 5 (7–3) | 6 (10–3) | 5 (8–3) | 5 (9.5–3) | 6 (10–4) | 5 (12–3) | 0.046 |
| Hospital stay (days) | 20.8 ± 13.1 | 21.9 ± 11.4 | 20.5 ± 10.0 | 21.7 ± 13.2 | 19.5 ± 11.5 | 21.8 ± 14.5 | 20.5 ± 17.2 | 14.4 ± 10.8 | 0.236 |
ICH intracranial hemorrhage, GI gastrointestinal, CRRT continuous renal replacement therapy, ICU intense care unit
Fig. 2a Ratio of mortality in different age groups. b Ratio and mortality of ≥ 70 years old patients each year, and the overall mortality fluctuation from 2011 to 2019
Fig. 3a Survival functions of different age groups. b The reintervention rate of different age groups. c. The ratio of readmission for aortic dissection